Sutro Biopharma Inc (STRO)
3.995
-0.16
(-3.73%)
USD |
NASDAQ |
May 17, 16:00
3.995
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Cash and Short Term Investments (Quarterly): 313.22M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 313.22M |
| December 31, 2023 | 375.62M |
| September 30, 2023 | 355.15M |
| June 30, 2023 | 391.64M |
| March 31, 2023 | 276.49M |
| December 31, 2022 | 334.36M |
| September 30, 2022 | 324.25M |
| June 30, 2022 | 225.64M |
| March 31, 2022 | 209.14M |
| December 31, 2021 | 197.94M |
| September 30, 2021 | 229.70M |
| June 30, 2021 | 258.70M |
| March 31, 2021 | 251.23M |
| Date | Value |
|---|---|
| December 31, 2020 | 368.14M |
| September 30, 2020 | 281.23M |
| June 30, 2020 | 250.46M |
| March 31, 2020 | 115.39M |
| December 31, 2019 | 117.86M |
| September 30, 2019 | 125.16M |
| June 30, 2019 | 153.16M |
| March 31, 2019 | 170.57M |
| December 31, 2018 | 204.49M |
| September 30, 2018 | 122.95M |
| June 30, 2018 | 25.42M |
| December 31, 2017 | 22.02M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
115.39M
Minimum
Mar 2020
391.64M
Maximum
Jun 2023
257.72M
Average
254.97M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AnaptysBio Inc | 354.66M |
| ABVC BioPharma Inc | 0.1395M |
| Reviva Pharmaceuticals Holdings Inc | 11.97M |
| Flora Growth Corp | 4.35M |
| Journey Medical Corp | 24.06M |